STAT+: Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial

The Story At A Glance

• • Moderna and Merck developed a personalized mRNA vaccine for stage III/IV melanoma.


• • Combining the vaccine with Keytruda reduced the risk of recurrence or death by 44% to 49%.


• • Long term data shows a 59% reduction in the risk of cancer metastasis.

Context
This personalized neoantigen vaccine uses a patient's specific tumor mutations to train the immune system. It is designed for use after surgical resection to prevent cancer relapse.

Christian Perspective
While medical advancement can preserve the life God has granted, we must remain wary of the mRNA platform. This technology was the foundation for the mandated medical procedures that violated individual liberty and bodily autonomy. True healing ultimately rests in the hands of the Creator rather than man made genetic interventions.

Implications
The push for mRNA technology threatens to normalize further government interference in personal health decisions. As these treatments become standard, the pressure to comply with experimental medical mandates will likely increase. Protecting the sanctity of the biological body is essential to maintaining our God given dignity.

Broader Trends
The rapid expansion of mRNA technology reflects a globalist drive toward centralized control over human biology. Large pharmaceutical corporations continue to consolidate power by pushing novel, high profit technologies. This trend aligns with a broader effort to subvert traditional views of natural health and individual sovereignty.

Takeaway
Prioritize natural health and traditional wellness to maintain biological integrity. Remain vigilant against any attempts by the state to mandate these specific mRNA technologies. Trust in God for ultimate protection while exercising extreme caution with experimental medical science.